Clinical Trial Update: Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial assessing the safety and efficacy of an allogenic umbilical cord blood-derived mesenchymal stem cell product for osteochondral lesion of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteochondral Lesion of Talus

Drugs mentioned

• Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product

Snippet

Sponsor: Samsung Medical Center | Conditions: Osteochondral Lesion of Talus | EARLY_Phase 1 | Status: UNKNOWN